InspireMD, Inc. (NYSE: NSPR) today announced that six month follow-up data from its CGuardTM CARENET (CARotid Embolic protection Study using ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE